Wilate

Wilate is a human coagulation factor VIII and von Willebrand factor complex used to manage bleeding disorders like hemophilia A and von Willebrand disease. This intravenous therapy supports blood clotting and is prescribed under medical supervision. Suitable for patients requiring factor replacement.

Wilate is used to treat and prevent bleeding episodes in patients with hemophilia A, a condition where blood lacks sufficient clotting factor VIII. It is also prescribed for von Willebrand disease, a disorder affecting von Willebrand factor, which plays a key role in blood clotting. This medication helps restore normal clotting function during bleeding events or before medical procedures.

Wilate works by supplementing the missing or deficient clotting factors in the blood, supporting the body’s natural ability to form clots. Patients may experience improved bleeding control and reduced frequency of bleeding episodes when used as directed. The effects are temporary and require regular administration to maintain clotting function.

Wilate should be handled and administered by a healthcare professional to ensure proper dosing and safety. Patients or caregivers should follow storage instructions, typically refrigeration, to maintain the medication’s potency. Always report any signs of allergic reactions or unusual symptoms to a doctor immediately.

Wilate may interact with other medications that affect blood clotting, such as anticoagulants or antiplatelet drugs. Patients should inform their healthcare provider about all medications, supplements, or herbal products they are using. Alcohol and certain foods may also influence clotting function and should be discussed with a doctor.